POSTTRANSPLANT DIABETES MELLITUS IN KIDNEY ALLOGRAFT RECIPIENTS: INCIDENCE, RISK FACTORS, AND MANAGEMENT1
Data up to Jan 2025
Total Citations Per Year
Abstract
References (27)
A COMPARISON OF TACROLIMUS (FK506) AND CYCLOSPORINE FOR IMMUNOSUPPRESSION AFTER CADAVERIC RENAL TRANSPLANTATION1
1997 • 1,128 citations
Recommendations for the Outpatient Surveillance of Renal Transplant Recipients
2000 • 610 citations
RANDOMIZED TRIAL OF TACROLIMUS (PROGRAF) IN COMBINATION WITH AZATHIOPRINE OR MYCHOPHENOLATE MOFETIL VERSUS CYCLOSPORINE (NEORAL) WITH MYCOPHENOLATE MOFETIL AFTER CADAVERIC KIDNEY TRANSPLANTATION1, 2
2000 • 291 citations
RACIAL DIFFERENCES IN RENAL TRANSPLANTATION AFTER IMMUNOSUPPRESSION WITH TACROLIMUS VERSUS CYCLOSPORINE1
1998 • 273 citations
DIABETES MELLITUS AFTER RENAL TRANSPLANTATION IN THE CYCLOSPORINE ERA
1991 • 234 citations
THE IMPACT OF CYCLOSPORINE AND COMBINATION IMMUNOSUPPRESSION ON THE INCIDENCE OF POSTTRANSPLANT DIABETES IN RENAL ALLOGRAFT RECIPIENTS
1987 • 222 citations
POSTTRANSPLANT HYPERGLYCEMIA
1989 • 194 citations
TRANSCRIPTIONAL INHIBITION OF INSULIN BY FK506 AND POSSIBLE INVOLVEMENT OF FK506 BINDING PROTEIN-12 IN PANCREATIC β-CELL
1995 • 174 citations
SAFETY AND EFFICACY OF TACROLIMUS IN COMBINATION WITH MYCOPHENOLATE MOFETIL (MMF) IN CADAVERIC RENAL TRANSPLANT RECIPIENTS1
2000 • 168 citations
A PROSPECTIVE RANDOMIZED TRIAL OF FK506-BASED IMMUNOSUPPRESSION AFTER RENAL TRANSPLANTATION1
1995 • 120 citations
A PROSPECTIVE, RANDOMIZED TRIAL OF TACROLIMUS/PREDNISONE VERSUS TACROLIMUS/PREDNISONE/MYCOPHENOLATE MOFETIL IN RENAL TRANSPLANT RECIPIENTS*
1999 • 115 citations
Impact and management of posttransplant diabetes mellitus.
2000 • 101 citations
Clinical efficacy of new thiazolidinediones and glinides in the treatment of type 2 diabetes mellitus
2000 • 87 citations
Single-center study: the diagnostic performance of contrast-enhanced ultrasound (CEUS) for assessing renal oncocytoma
2020 • 52 citations
HLA-A28 and Steroid-Induced Diabetes in Renal Transplant Patients
1980 • 49 citations
Effects of Cyclosporin on Insulin and C-Peptide Secretion in Healthy Beagles
1989 • 47 citations
Diabetes mellitus--a more-common-than-believed complication of renal transplantation.
1979 • 39 citations
Peripheral insulin resistance and decreased insulin secretion after cyclosporine A treatment.
1988 • 30 citations
Thiazolidinediones, dyslipidaemia and insulin resistance syndrome
2000 • 29 citations
New classification and diagnostic criteria for diabetes mellitus
1998 • 28 citations
A PROSPECTIVE, RANDOMIZED, MULTICENTRE STUDY TO COMPARE THE EFFICACY AND SAFETY OF TACROLIMUS AND CICLOSPORIN-MICROEMULSION IN RENAL TRANSPLANTATION.
2000 • 24 citations
THE EFFECTS OF FK506 AND CYCLOSPORINE ON THE EXOCRINE FUNCTION OF THE RAT PANCREAS
1992 • 19 citations
EARLY CORTICOSTEROID CESSATION AT ONE WEEK FOLLOWING KIDNEY TRANSPLANT UNDER TACROLIMUS AND MYCOPHENOLATE MOFETIL (MMF) IMMUNOSUPPRESION, THREE-YEAR FOLLOW-UP.
2000 • 19 citations
Corticosteroid withdrawal under tacrolimus primary and rescue therapy in renal transplantation: the Chicago experience
1999 • 16 citations
KIDNEY TRANSPLANTATION WITHOUT PREDNISONE.
2000 • 14 citations
TACROLIMUS VERSUS CYCLOSPORINE IN KIDNEY TRANSPLANTATION: FIVE-YEAR SURVIVAL RESULTS OF THE U.S. MULTICENTER, RANDOMIZED, COMPARATIVE STUDY.
2000 • 11 citations
TWO YEAR FOLLOWUP OF A RANDOMIZED MULTICENTER KIDNEY TRANSPLANT STUDY COMPARING TACROLIMUS(PG)+AZATHIOPRINE(AZA) VS. CYCLOSPORINE(NEORAL)+MYCOPHENOLATE MOFETIL(MMF) VS. TACROLIMUS+MMF.
2000 • 5 citations